Drug Shortage Report for GD-DICLOFENAC/MISOPROSTOL 50

Last updated on 2023-02-11 History
Report ID 180226
Drug Identification Number 02341689
Brand name GD-DICLOFENAC/MISOPROSTOL 50
Common or Proper name GD-DICLOFENAC/MISOPROSTOL
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) MISOPROSTOL DICLOFENAC SODIUM
Strength(s) 200MCG 50MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 250's
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-01-10
Actual start date 2023-01-10
Estimated end date 2023-02-10
Actual end date 2023-02-10
Shortage status Resolved
Updated date 2023-02-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-02-11 English Compare
v11 2023-02-10 French Compare
v10 2023-02-10 English Compare
v9 2023-01-31 French Compare
v8 2023-01-31 English Compare
v7 2023-01-30 French Compare
v6 2023-01-30 English Compare
v5 2023-01-11 French Compare
v4 2023-01-11 English Compare
v3 2023-01-11 English Compare
v2 2023-01-09 French Compare
v1 2023-01-09 English Compare

Showing 1 to 12 of 12